N-benzyl-2-(3-fluorophenyl)-4-methylthiazole-5-carboxamide | 1196065-70-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: N-benzyl-2-(3-fluorophenyl)-4-methylthiazole-5-carboxamide
• 英文别名: N-benzyl-2-(3-fluorophenyl)-4-methyl-1,3-thiazole-5-carboxamide
• CAS: 1196065-70-9
• 化学式: C₁₈H₁₅FN₂OS
• 分子量: 326.394
• InChiKey: XHATXBVYQSTQPJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  70.2
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2-bromo-4-methyl-thiazole-5-carboxylic acid benzylamide 、 aqueous cesium carbonate 、 3-氟苯基硼酸 生成 N-benzyl-2-(3-fluorophenyl)-4-methylthiazole-5-carboxamide
  参考文献：
  名称：

  摘要：

  DOI：

文献信息

• METHOD FOR ASSAYING COMPOUNDS OR AGENTS FOR ABILITY TO DISPLACE POTENT LIGANDS OF HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE
  申请人：Maxey Kirk W.

  公开号：US20090286261A1

  公开（公告）日：2009-11-19

  An exemplary embodiment may be directed to a fluorescence polarization assay that screens compounds or agents for their affinity to hematopoietic prostaglandin D synthase (H-PGDS) based on their ability to displace a fluorophore-containing detection analyte bound to an enzyme comprising the primary amino acid sequence of H-PGDS. Another exemplary embodiment utilizes an enzyme having a maltose binding protein amino-acid sequence fused with an N-terminus of the enzyme.

  一个示范性实施例可能涉及一种荧光极化测定法，该方法通过检测化合物或试剂对血液造血素D合成酶（H-PGDS）的亲和力来筛选，其基于它们能够将结合到具有H-PGDS主要氨基酸序列的酶上的含荧光团的检测分析物位移开。另一个示范性实施例利用具有麦芽糖结合蛋白氨基酸序列的酶，与酶的N-末端融合。
• US8440417B2
  申请人：——

  公开号：US8440417B2

  公开（公告）日：2013-05-14
• [EN] METHODS FOR ASSAYING COMPOUNDS OR AGENTS FOR ABILITY TO DISPLACE POTENT LIGANDS OF HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE<br/>[FR] PROCÉDÉS D'ÉVALUATION DE LA CAPACITÉ DE COMPOSÉS OU D'AGENTS À DÉPLACER DE PUISSANTS LIGANDS DE LA PROSTAGLANDINE D SYNTHASE HÉMATOPOÏÉTIQUE
  申请人：CAYMAN CHEM CO

  公开号：WO2009140364A2

  公开（公告）日：2009-11-19

  An exemplary embodiment may be directed to a fluorescence polarization assay that screens compounds or agents for their affinity to hematopoietic prostaglandin D synthase (H-PGDS) based on their ability to displace a fluorophore-containing detection analyte bound to an enzyme comprising the primary amino acid sequence of H-PGDS. Another exemplary embodiment utilizes an enzyme having a maltose binding protein amino-acid sequence fused with an N- terminus of the enzyme.